Chin C.H., et al., 2014 cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 8 Suppl 4(Suppl 4): p. S11

Deng X, Liu Z, Han S (2023) Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells. Open Med (Wars) 18(1):20230855

Article  CAS  PubMed  Google Scholar 

Garrett WS, Gordon JI, Glimcher LH (2010) Homeostasis and inflammation in the intestine. Cell 140(6):859–870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gasbarrini G, Montalto M (1999) Structure and function of tight junctions. Role in intestinal barrier. Ital J Gastroenterol Hepatol 31(6):481–488

Gu X et al (2023) Cimifugin suppresses type 2 airway inflammation by binding to SPR and regulating its protein expression in a non-enzymatic manner. Phytomedicine 111:154657

Article  CAS  PubMed  Google Scholar 

Guo J et al (2022) Cold exposure induces intestinal barrier damage and endoplasmic reticulum stress in the colon via the SIRT1/Nrf2 signaling pathway. Front Physiol 13:822348

Article  PubMed  PubMed Central  Google Scholar 

Gwee KA et al (2003) Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 52(4):523–526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han B et al (2019) Cimifugin inhibits inflammatory responses of RAW264.7 cells induced by lipopolysaccharide. Med Sci Monit 25:409–417

Article  CAS  PubMed  PubMed Central  Google Scholar 

He S et al (2020) Ferulic acid ameliorates lipopolysaccharide-induced barrier dysfunction via microRNA-200c-3p-mediated activation of PI3K/AKT pathway in Caco-2 cells. Front Pharmacol 11:376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holmberg FEO et al (2018) Intestinal barrier integrity and inflammatory bowel disease: stem cell-based approaches to regenerate the barrier. J Tissue Eng Regen Med 12(4):923–935

Article  CAS  PubMed  Google Scholar 

Hou Q et al (2019) Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways. BMC Complement Altern Med 19(1):337

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Y et al (2021) Piezo1 regulates intestinal epithelial function by affecting the tight junction protein claudin-1 via the ROCK pathway. Life Sci 275:119254

Article  CAS  PubMed  Google Scholar 

Kimura H et al (1997) Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC-6 rat intestinal crypt cells. J Cell Physiol 171(3):284–290

Article  CAS  PubMed  Google Scholar 

Kumar S, Singh P, Kumar A (2022) Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clin J Gastroenterol 15(1):1–10

Article  PubMed  Google Scholar 

Lacy BE, Moreau JC (2016) Diarrhea-predominant irritable bowel syndrome: diagnosis, etiology, and new treatment considerations. J Am Assoc Nurse Pract 28(7):393–404

Article  PubMed  Google Scholar 

Li S, Zhang B (2013) Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11(2):110–120

Article  PubMed  Google Scholar 

Li M et al (2021) Glutamine blocks interleukin-13-induced intestinal epithelial barrier dysfunction. Digestion 102(2):170–179

Article  CAS  PubMed  Google Scholar 

Li X et al (2023) Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3/p53/SLC7A11 signaling pathway. J Ethnopharmacol 316:116689

Article  CAS  PubMed  Google Scholar 

Liu Y et al (2021) Vitamin D(3) mitigates lipopolysaccharide-induced oxidative stress, tight junction damage and intestinal inflammatory response in yellow catfish, Pelteobagrus fulvidraco. Comp Biochem Physiol C Toxicol Pharmacol 243:108982

Article  CAS  PubMed  Google Scholar 

Liu A et al (2020) Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway. Biosci Rep 40(6):BSR20200471

Martínez C et al (2012) Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver 6(3):305–315

Article  PubMed  PubMed Central  Google Scholar 

Martínez C et al (2012) The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol 107(5):736–746

Article  PubMed  Google Scholar 

Nitti M et al (2017) HO-1 induction in cancer progression: a matter of cell adaptation. Antioxidants (Basel) 6(2):29

Article  PubMed  Google Scholar 

Otani T, Furuse M (2020) Tight junction structure and function revisited. Trends Cell Biol 30(10):805–817

Article  CAS  PubMed  Google Scholar 

Sinagra E et al (2016) Inflammation in irritable bowel syndrome: myth or new treatment target? World J Gastroenterol 22(7):2242–2255

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun H et al (2016) Fermented Yupingfeng polysaccharides enhance immunity by improving the foregut microflora and intestinal barrier in weaning rex rabbits. Appl Microbiol Biotechnol 100(18):8105–8120

Article  CAS  PubMed  Google Scholar 

Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9(11):799–809

Article  CAS  PubMed  Google Scholar 

Wang L et al (2023) Therapeutic effects of paeoniflorin on irritable bowel syndrome in rats. J Vet Sci 24(3):e23

Article  PubMed  PubMed Central  Google Scholar 

Wang Y et al (2023) Lidocaine ameliorates intestinal barrier dysfunction in irritable bowel syndrome by modulating corticotropin-releasing hormone receptor 2. Neurogastroenterol Motil 35(11):e14677

Article  CAS  PubMed  Google Scholar 

Wang D et al (2023) Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer. Front Genet 14:1022265

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu JJ et al (2021) Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury. Int J Cardiol 342:82–93

Article  PubMed  Google Scholar 

Yan J et al (2021) Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4. Cell Calcium 97:102429

Article  CAS  PubMed  Google Scholar 

Yang M et al (2018) A network pharmacology approach to uncover the molecular mechanisms of herbal formula Ban-Xia-Xie-Xin-Tang. Evid Based Complement Alternat Med 2018:4050714

Article  PubMed  PubMed Central  Google Scholar 

Yang W et al (2022) Cimifugin ameliorates lipotoxicity-induced hepatocyte damage and steatosis through TLR4/p38 MAPK- and SIRT1-involved pathways. Oxid Med Cell Longev 2022:4557532

PubMed  PubMed Central  Google Scholar 

Yang Y et al (2022) Regulation of SIRT1 and its roles in inflammation. Fr